| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0039 | 1 |